Portrait Pepscan Therapeutics is a product focused immunotherapy company based in the Netherlands. It has developed a pipeline of therapeutic vaccine and antibody programs of which the most advanced is in Phase II clinical testing. Pepscan's proprietary CLIPS(tm) technology has been proven to yield functional antibodies reactive with a range of complex proteins, including GPCRs.